This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Liver Cirrhosis or Portal Hypertension
and you are
over 20
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Recent studies indicate that probiotics can stimulate intestinal immunity and tighten the junctions of epithelial cells. By these ways, probiotics can reduce bacterial translocation; hence, they can ameliorate systemic inflammatory status. Because cirrhotic patients with portal hypertension often suffer from infections from intestinal flora, the investigators speculate that probiotics will be beneficial to those patients.

Provided treatments

  • : GK#10
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT01598064. The sponsor of the trial is Po-Lin Chen, MD and it is looking for 49 volunteers for the current phase.
Official trial title:
Clinical Trial of Probiotics in Preventing Complication Related to Portal Hypertension in Cirrhotic Patients